Chapter 71

Reference

  1. Abboud P, Lemee V, Gargala G, et al. 2001. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 32:1792-1794.
  2. Andrade SG, Rassi A, Magalhaes JB, et al. 1992. Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains. Trans R Soc Trop Med Hyg 86:624-626.
  3. Armitage K, Flanigan T, Carey J, et al. 1992. Treatment of cryptosporidiosis with paromomycin. Arch Intern Med 152:2497-2499.
  4. Aronson NE, Wortmann GW, Johnson SC, et al. 1998. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis 27:1457-1464.
  5. Ayoob AL, Hackner SG, Prittie J. 2010. Clinical management of canine babesiosis. J Vet Emerg Crit Care 20:77-89.
  6. Ayoob AL, Prittie J, Hackner SG. 2010. Feline babesiosis. J Vet Emerg Crit Care 20:90-97.
  7. Bailey JM, Erramouspe J. 2004. Nitazoxanide treatment for giardiasis and cryptosporidiosis in children. Ann Pharmacother 38:634-640.
  8. Baneth G, Shaw S. 2002. Chemotherapy of canine leishmaniasis. Vet Parasitol 106:315-324.
  9. Barr SC. 2009. Canine Chagas’ disease (American trypanosomiasis) in North America. Vet Clin Small Anim 39:1055-1064.
  10. Barr SC, Bowman DD, Frongillo MF, et al. 1998. Efficacy of a drug combination of praziquantel, pyrantel pamoate, and febantel against giardiasis in dogs. Am J Vet Res 59:1134-1136.
  11. Barr SC, Bowman DD, Heller RL, et al. 1993. Efficacy of albendazole against giardiasis in dogs. Am J Vet Res 54:926-928.
  12. Barr SC, Bowman DD, Heller RL. 1994. Efficacy of fenbendazole against giardiasis in dogs. Am J Vet Res 55:988-990.
  13. Barr SC, Jamrosz GF, Hornbuckle WE, et al. 1994. Use of paromomycin for treatment of cryptosporidiosis in a cat. J Am Vet Med Assoc 205:1742-1743.
  14. Belhadjali H, Elhani I, Youssef M, et al. 2009. [Cutaneous leishmaniasis treatment by metronidazole: study of 30 cases]. Presse Med 38:325-326.
  15. Bello TR, Allen TM. 2008. An intensive approach in the treatment of clinical equine protozoal myeloencephalitis. J Equine Vet Sci 28:479-483.
  16. Berman JD. 1997. Human leishmaniasis: clinical, diagnostic, and therapeutic developments in the last 10 years. Clin Infect Dis 24:684-703.
  17. Bianciardi P, Fasanella A, Manzillo VF, et al. 2004. The efficacy of enrofloxacin, alone or in combination with metronidazole in the therapy of canine leishmaniasis. Parasitol Res 93:486-492, 2004.
  18. 17a. Bisby TM, Holman PJ, Pitoc GA, et al. 2010. Sarcocystis sp. encephalomyelitis in a cat. Vet Clin Pathol 39:105-112.
  19. Bowman DD, Liotta JL, Ulrich M, et al. 2009. Treatment of naturally occurring asymptomatic Giardia sp. in dogs with Drontal Plus flavour tablets. Parasitol Res 105:S125-S134.
  20. Burch D. Young S, Watson E. 2007. Treatment of histomonosis in turkeys with tiamulin. Vet Rec 161:864.
  21. Caldas S, Santos FM, de Lana M, et al. 2008. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole. Exp Parasitol 118:315-323.
  22. Campbell WC. 2008. History of the discovery of sulfaquinoxaline as a coccidiostat. J Parasitol 94:934-945.
  23. Cavaliero T, Arnold P, Mathis A, et al. 1999. Clinical serologic and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum. J Vet Intern Med 13:330-334.
  24. Caylor KB, Cassimatis MK. 2001. Metronidazole neurotoxicosis in two cats. J Am Anim Hosp Assoc 37:258-262.
  25. Chang HR, Comte R, Pechere JC. 1990. In vitro and in vivo effects of doxycycline of Toxoplasma gondii. Antimicrob Agents Chemother 34:775-780.
  26. Charles SD, Chopade HM, Ciszewski DK, et al. 2007. Safety of 5% ponazuril (toltrazuril sulfone) oral suspension and efficacy against naturally acquired Cystoisospora ohioensis-like infection in beagle puppies. Parasitol Res 101:S137-S144.
  27. Chon SK, Kim NS. 2005. Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs. Parasitol Res 97:445-451.
  28. 26a. Cohn LA, Birkenheuer AJ, Brunker JD, et al. 2011. Efficacy of atovaquone and azithromycin or imidocarb dipropionate in cats with acute cytauxzoonosis. J Vet Intern Med 25:55-60.
  29. Collett MG. 2000. Survey of canine babesiosis in South Africa. J South Afr Vet Assoc 71:180-186.
  30. Cortadellas O. 2003. Initial and long-term efficacy of a lipid emulsion of amphotericin B desoxycholate in the management of canine leishmaniasis. J Vet Intern Med 17:808-812.
  31. Demicheli C, Ochoa R, da Silva JB, et al. 2004. Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis. Antimicrob Agents Chemother 48:100-103.
  32. Denerolle P, Bourdoiseau G. 1999. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J Vet Intern Med 13:413-415.
  33. Dow SW, LeCouteur RA, Poss ML, et al. 1989. Central nervous system toxicosis associated with metronidazole treatment of dogs. Five cases (1984-1987). J Am Vet Med Assoc 195:365-368.
  34. Dubey JP, Lindsay DS, Lappin MR. 2009. Toxoplasmosis and other intestinal coccidial infections in cats and dogs. Vet Clin Small Anim 39:1009-1034.
  35. Dubey JP, Vianna MCB, Kwok OCH, et al 2007. Neosporosis in beagle dogs: clinical signs, diagnosis, treatment, isolation and genetic characterization of Neospora caninum. Vet Parasitol 149:158-166.
  36. Dunbar MR, Foreyt WJ. 1985. Prevention of coccidiosis in domestic dogs and captive coyotes (Canis latrans) with sulfadimethoxine-ormetoprim combination. Am J Vet Res 46:1899-1902.
  37. Eddlestone SM, Neer MT, Gaunt SD, et al. 2005. Failure of imidocarb dipropionate to clear experimentally induced Ehrlichia canis infection in dogs. 2005 ACVIM Forum abstract no 134. J Vet Intern Med 19:436.
  38. Egbe-Nwiyi TN, Antia RE. 1993. The effect of trypanocidal drug treatment on the haematological changes in Trypanosoma brucei brucei infected splenectomized dogs. Vet Parasitol 50:23-33.
  39. Euzeby J, S. Prom-Tep S, Rossignol JF. 1980. Study of the antihelminthic properties of nitazoxanide in dog, cat and sheep. Rev Med Vet 131:687-696.
  40. Evans J, Levesque D, Knowles K, et al. 2003. Diazepam as a treatment for metronidazole toxicosis in dogs: a retrospective study of 21 cases. J Vet Intern Med 17:304-310.
  41. 38a. Fitzgerald L, Bennett M, Ng J, et al. 2011. Morphological and molecular characterization of a mixed Cryptosporidium muris/Cryptosporidium felis infection in a cat. Vet Parasitol 175:160-164.
  42. Font A, Roura X, Fondevila D, et al. 1996. Canine mucosal leishmaniasis. J Am Anim Hosp Assoc 32:131-137.
  43. Foster DM, Gookin JL, Poore MF, et al. 2004. Outcome of cats with diarrhea and Tritrichomonas foetus infection. J Am Vet Med Assoc 225:888-892.
  44. 40a. Freeman K. 2010. Update on the diagnosis and management of Leishmania spp. infections in dogs in the United States. Top Comp Anim Pract 25:149-154.
  45. Fuertes MA, Nguewa PA, Castilla J, et al. 2008. Anticancer compounds as leishmanicidal drugs: Challenges in chemotherapy and future perspectives. Curr Med Chem 15:433-439.
  46. Fung HB, Doan TL. 2005. Tinidazole: A nitroimidazole antiprotozoal agent. Clin Ther 27:1859-1884.
  47. Furr M, Kennedy T. 2001. Cerebrospinal fluid and serum concentrations of ponazuril in horses. Vet Therap 2:232-237.
  48. Gardner TB, Hill DR. 2001. Treatment of giardiasis. Clin Microbiol Rev 14:114-128.
  49. Gary AT, Kerl ME, Wiedmeyer CE, et al. 2004. Bone marrow hypoplasia associated with fenbendazole administration in a dog. J Am Anim Hosp Assoc 40:224-229.
  50. Ginel PJ, Lucena R, Lopez R, et al. 1998. Use of allopurinol for maintenance of remission in dogs with leishmaniasis. J Small Anim Pract 39:271-274.
  51. Gómez-Ochoa P, Castillo JA, Gascón M, et al. 2009. Use of domperidone in the treatment of canine visceral leishmaniasis. Vet J 179:259-263.
  52. Gookin JL, Copple CN, Papich MG, et al. 2006. Efficacy of ronidazole for treatment of feline Tritrichomonas foetus infection. J Vet Intern Med 20:536-543.
  53. Gookin JL, Stauffer SH, Coccaro MR, et al. 2007. Efficacy of tinidazole for treatment of cats experimentally infected with Tritrichomonas foetus. Am J Vet Res 68:1085-1088.
  54. Gottstein B, Eperon S, Dai WJ, et al. 2001. Efficacy of toltrazuril against experimental Neospora caninum infection in mice. Parasitol Res 87:43-48.
  55. Gottstein B, Kritzner S, Sager H, et al. 2002. Toltrazuril/ponazuril highly affects Neospora caninum in experimentally infected mice and calves, abstract E. 7. From the Joint Annual Meeting, Parasitol. Nashville, July 13–16.
  56. Gramiccia M, Gradoni L, Orsini S. 1992. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several causes of drug treatment. Ann Trop Med Parasitol 86:613-620.
  57. Griffin B. 2007. Personal communication on treatment of coccidiosis in cats with ponazuril. Cornell University, Ithaca, NY.
  58. Greene CE. 1990. Antiprotozoal chemotherapy, pp 758-762. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  59. Greene CE, Latimer K, Hopper E, et al. 1999. Administration of diminazene aceturate or imidocarb dipropionate for treatment of cytauxzoonosis in cats. J Am Vet Med Assoc 215:497-500.
  60. Greene CE, Watson ADJ. 1998. Antiprotozoal chemotherapy, pp 441-444. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  61. Groman R. 2000. Metronidazole. Compend Contin Educ Pract Vet 22:1104-1107.
  62. Guedes PM, Urbina JA, de Lana M, et al. 2004. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts. Antimicrob Agents Chemother 48:4286-4292.
  63. Guedes PM, Veloso VM, Tafuri WL, et al. 2002. The dog as model for chemotherapy of the Chagas’ disease. Acta Trop 84:9-17.
  64. 59a. Gunn-Moore D, Lalor S. 2011. Treatment of diarrhea in cats caused by Tritrichomonas foetus. Vet Rec 168:56-57.
  65. Hailu A, Menon JN, Berhe N, et al. 2001. Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cure. J Infect Dis 184:112-115.
  66. Haque R, Huston CD, Hughes M, et al. 2003. Current concepts amebiasis. N Eng J Med 348:1565-1573.
  67. Hausen MA, Freitas JCM, Monteiro-Leal LH. 2006. The effects of metronidazole and furazolidone during Giardia differentiation into cysts. Exp Parasitol 113:135-141.
  68. Hausen MA, de Oliveira RP, Gadelha APR, et al. 2009. Giardia lamblia: a report of drug effects under cell differentiation. Parasitol Res 105:789-796.
  69. Hay WH, Shell LG, Lindsay DS, et al. 1990. Diagnosis and treatment of Neospora caninum infection in a dog. J Am Vet Med Assoc 197:87-89.
  70. Herwaldt BL, Neva FA, Berman JD. 1992. Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med 327:498.
  71. Hiles RA, Mong S, Bekersky I, et al. 1994. Inhalation toxicity of aerosolized pentamidine isethionate in rats and dogs. Fundam Appl Toxicol 23:382-390.
  72. Holliday M, Deni D, Gunn-Moore DA. 2009. Tritrichomonas foetus infection in cats with diarrhea in a rescue colony. J Feline Med Surg 11:131-134.
  73. Holman PJ, Snowden KF. 2009. Canine hepatozoonosis and babesiosis and feline cytauxzoonosis. Vet Clin Small Anim 39:1035-1053.
  74. Homer MJ, Aguilar-Delfin I, Telford SR, et al. 2000. Babesiosis. Clin Microbiol Rev 13:451-469.
  75. Hughes WT. 1995. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol 8:247-252.
  76. 70a. Hwang SJ, Yamasaki M, Nakamura K, et al. 2010. Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro. J Vet Med Sci 72:765-771.
  77. Jefferies R, Ryan UM, Jardine J, et al. 2007. Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy. Exp Parasitol 117:115-123.
  78. João A, Pereira MA, Cortes S, et al. 2006. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission. J Vet Med A 53:540-545.
  79. Johnston KL, Lamport AI, Ballèvre OP. 2000. Effects of oral administration of metronidazole on small intestinal bacteria and nutrients of cats. Am J Vet Res 61:1106-1112.
  80. Joubert KE, Kettner F, Lobetti RG, et al. 2003. The effects of diminazene aceturate on systemic blood pressure in clinically healthy adult dogs. J South Afr Vet Assoc 74:69-71.
  81. Kather EJ, Marks SL, Kass PH. 2007. Determination of the in vitro susceptibility of feline Tritrichomonas foetus to 5 antimicrobial agents. J Vet Intern Med 21: 966-970.
  82. Keith CL, Radecki SV, Lappin MR. 2003. Evaluation of fenbendazole for treatment of Giardia infection in cats concurrently infected with Cryptosporidium parvum. Am J Vet Res 64:1027-1029.
  83. Kock N, Kelly P. 1991. Massive hepatic necrosis associated with accidental imidocarb dipropionate toxicosis in a dog. J Comp Pathol 104:113-116.
  84. Koutinas AF, Saridomichelakis MN, Mylonakis ME, et al. 2001. A randomized blinded placebo-controlled clinical trial with allopurinol in canine leishmaniosis. Vet Parasitol 98:247-261.
  85. Krause PJ, Lepore T, Sikand VK, et al. 2000. Atovaquone and azithromycin for the treatment of babesiosis. N Eng J Med 343:1454-1458.
  86. Kritzner S, Sager H, Blum J, et al. 2002. An explorative study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves experimentally infected with Neospora caninum. Ann Clin Microbiol Antimicrob 1:4.
  87. Laber G. 1988. Investigation of pharmacokinetic parameters of tiamulin after intramuscular and subcutaneous administration in normal dogs. J Vet Pharmacol Therap 11:45-49.
  88. Lamothe J. 1997. A new prospect on canine leishmaniasis: treatment with amphotericin B. Prat Med Chir Comp 32:133-141.
  89. Lamothe J. 2001. Activity of amphotericin B in lipid emulsion in the initial treatment of canine leishmaniasis. J Small Anim Pract 42:170-175.
  90. Lamothe J. 2009. Some remarks about the LeishVet directions for the treatment of leishmaniosis. Vet Parasitol 169:416-417.
  91. Lappin MR. 2005. Enteric protozoal diseases. Vet Clin Small Anim 35:81-88.
  92. Leiva M, Lloret A, Pena T, et al. 2008. Therapy of ocular and visceral leishmaniasis in a cat. Vet Ophthalmol 8: 71-75.
  93. Lester SJ, Kenyon JE. 1996. Use of allopurinol to treat visceral leishmaniasis in a dog. J Am Vet Med Assoc 209:615-617.
  94. Lin MY, Huang HP. 2010. Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoni. Acta Vet Scand 52:27.
  95. Lindsay DS, Blagburn BL. 1991. Coccidial parasites of cats and dogs. Compend Contin Educ Pract Vet 13:759-765.
  96. Ling GV, Ruby AL, Harrold DR, et al. 1991. Xanthene-containing urinary calculi in dogs given allopurinol. J Am Vet Med Assoc 198:1935-1940.
  97. Liste F, Gascon M. 1995. Allopurinol in the treatment of canine visceral leishmaniasis. Vet Rec 137:23-24.
  98. Lloyd S, Smith J. 2001. Activity of toltrazuril and diclazuril against Isospora species in kittens and puppies. Vet Rec 148:509-511.
  99. Lynen L, Van Damme W. 1992. Local application of diminazene aceturate: an effective treatment for cutaneous leishmaniasis. Ann Soc Belge Med Trop 72:13-19.
  100. MacIntire DK, Vincent-Johnson NA, Kane CW, et al. 2001. Treatment of dogs infected with Hepatozoon americanum: 53 cases (1989-1998). J Am Vet Med Assoc 218:77-82.
  101. Manna L, Reale S, Picillo E, et al. 2008. Interferon-gamma (IFN-γ). IL4 expression levels and Leishmania DNA load as prognostic markers of monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol. Cytokine 44:288-292.
  102. Manna L, Reale S, Vitale F, et al. 2008. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. Vet J 177:279-282.
  103. Manna L, Vitale F, Reale S, et al. 2009. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis. Vet J 182:441-445.
  104. Marr JJ. 1991. Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J Lab Clin Med 118:111-119.
  105. Martinez S, Marr JJ. 1992. Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med 326:741-744.
  106. Mateo M, Maynard L, Vischer PB, et al. 2009. Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis. Parasitol Res 105:155-162, 2009.
  107. Matsuu A, Yamasaki M, Xuan X, et al. 2008. In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Vet Parasitol 157:1-8.
  108. Matthewmann LA, Kelly PJ, Brouqui P, et al. 1994. Further evidence for the efficacy of imidocarb dipropionate in the treatment of Ehrlichia canis infection. J South Afr Vet Assoc 65:104-107.
  109. Mayhew IG, Smith KC, Dubey JP, et al. 1991. Treatment of encephalomyelitis due to Neospora caninum in a litter of puppies. J Small Anim Pract 32:609-612.
  110. McKeller QA, Galbraith EA, Baxter P. 1993. Oral absorption and bioavailability of fenbendazole in the dog and the effect of concurrent ingestion of food. J Vet Pharmacol Ther 16:189-198.
  111. Meyer EK. 1998. Adverse events associated with albendazole and other products used for treatment of giardiasis in dogs. J Am Vet Med Assoc 213:44-46.
  112. Meyerhoff A. 1999. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 28:42-48.
  113. Milner RJ, Reyers F, Taylor JH, et al. 1997. The effect of diminazene aceturate on cholinesterase activity in dogs with canine babesiosis. J South Afr Vet Assoc 68:111-113.
  114. Molina JM, Tourneru M, Sarfati C, et al. 2002. Fumagillin treatment of intestinal microsporidiosis. N Eng J Med 346:1963-1969.
  115. Montoya A, Dado D, Mateo M, et al. 2008. Efficacy of Drontal flavour Plus (50 mg praziquantel, 144 mg pyrantel embonate, 150 mg febantel per tablet) against Giardia sp. in naturally infected dogs. Parasitol Res 103:1141-1144.
  116. Moreno J, Nieto J, Chamizo C, et al. 1999. The immune response and PBMC subsets in canine visceral leishmaniosis before, and after chemotherapy. Vet Immunol Immunopathol 71:181-195.
  117. Motzel SL, Wagner JE. 1990. Treatment of experimentally induced cytauxzoonosis in cats with parvaquone and buparvaquone. Vet Parasitol 35:131-138.
  118. Naidoo V, Mulders MSG, Swan GE. 2009. The intravenous pharmacokinetics of diminazene in healthy dogs. J S Afr Vet Assoc 80:215-219.
  119. Nash TE, Ohl CA, Thomas E, et al. 2001. Treatment of patients with refractory giardiasis. Clin Infect Dis 33:22-28.
  120. Noli C, Auxilia ST. 2005. Treatment of Old World visceral leishmaniasis: a systematic review. Vet Dermatol 16: 213-232.
  121. Nuttall TJ, Burrow R, Fraser I, et al. 2005. Thrombo-ischaemic pinnal necrosis associated with fenbendazole treatment in a dog. J Small Anim Pract 46:243-246.
  122. 115a. Oines O, Storli K, Brun-Hansen H. 2010. First case of babesiosis caused by Babesia canis canis in a dog from Norway. Vet Parasitol 171:350-353.
  123. Oliva G, Gradoni L, Ciaramella P, et al. 1995. Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum. J Antimicrob Chemother 36:1013-1019.
  124. Oliva G, Roura X, Crotti A, et al. 2010. Guidelines for treatment of leishmaniasis in dogs. J Am Vet Med Assoc 236:1192-1198.
  125. Ollivett TL, Nydam DV, Bowman DD, et al. 2009. Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves. J Dairy Sci 92: 1643-1648.
  126. Olson EJ, Morales SC, McVey AS, et al. 2005. Putative metronidazole neurotoxicosis in a cat. Vet Pathol 42:665-669.
  127. Onyeyili PA, Anika SM. 1990. Effects of the combination of DL-α-difluoromethylornithine and diminazene aceturate in Trypanosoma congolense infection of dogs. Vet Parasitol 37:9-19.
  128. Onyeyili PA, Anika SM. 1991. Diminazene aceturate residues in the tissues of healthy, Trypanosoma congolense and Trypanosoma brucei brucei infected dogs. Br Vet J 147:155-158.
  129. 121a. Papich M. 2010. Clarification of drugs used to treat leishmaniasis. J Am Vet Med Assoc 237:49-4963.
  130. Payne PA, Artzer M. 2009. The biology and control of Giardia spp. and Tritrichomonas foetus. Vet Clin Small Anim 39: 993-1007.
  131. Payne PA, Ridley RK, Dryden MW, et al. 2002. Efficacy of a combination febantel-praziquantel-pyrantel product, with or without vaccination with a commercial Giardia vaccine, for treatment of dogs with naturally occurring giardiasis. J Am Vet Med Assoc 220:330-333.
  132. Pennisi MG, De Majo M, Masucci M, et al. 2005. Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin. Vet Rec 156:346-349.
  133. Pennisi MG, Giudice SL, Masucci M, et al. 2008. Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis. Vet Res Commun 32:S303-S305.
  134. Pennisi MG, Reale S, Giudice SL, et al. 2005. Real-time PCR in dogs treated for leishmaniasis with allopurinol. Vet Res Commun 20:301-303.
  135. Penzhorn BL, Lewis BD, DeWaal DT, et al. 1995. Sterilization of Babesia canis infections by imidocarb alone or in combination with diminazene. J South Afr Vet Assoc 66:157-159.
  136. Peregrine AS, Mamman M. 1993. Pharmacology of diminazene: a review. Acta Trop 54:185-203.
  137. Petersen CA, Barr SC. 2009. Canine leishmaniasis in North America: emerging or newly recognized? Vet Clin Small Anim 39:1065-1074.
  138. Petri WA, Singh U. 1999. Diagnosis and management of amebiasis. Clin Infect Dis 29:1117-1125.
  139. Poli A, Sozzi S, Guidi G, et al. 1997. Comparison of aminosidine (paromomycin) and sodium stilbogluconate for treatment of canine leishmaniasis. Vet Parasitol 71:263-271.
  140. Prasad R, Kumar R, Jaiswal BP, et al. 2004. Miltefosine: an oral drug for visceral leishmaniasis. Indian J Pediatr 71:143-144.
  141. Rehg JE, Hancock ML, Woodmansee DB. 1988. Anticryptosporidial activity of sulfadimethoxine. Antimicrob Agents Chemother 12:1907-1908.
  142. Reinemeyer CR, Lindsay DS, Mitchell SM, et al. 2007. Development of experimental Cystoisospora canis infection models in beagle puppies and efficacy evaluation of 5% ponazuril (toltrazuril sulfone) oral suspension. Parasitol Res 101:S129-S136.
  143. Rhalem A, Sahibi H, Lasri S, et al. 1999. Analysis of immune responses in dogs with canine visceral leishmaniosis before, and after, drug treatment. Vet Immunol Immunopathol 71:69-76.
  144. Riberio RR, Moura EP, Pimentel VM, et al. 2008. Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate. Antimicrob Agents Chemother 52:2564-2572.
  145. Rosado TW, Specht A, Marks SL. 2007. Neurotoxicosis in 4 cats receiving ronidazole. J Vet Intern Med 21:328-331.
  146. Rossignol JF. 2010. Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol 124:45-53.
  147. Rosypal AC, Hall JE, Bakunova S, et al. 2007. In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum. Vet Parasitol 145:207-216.
  148. Riera C, Valladares JE, Gallego M, et al. 1999. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate. Vet Parasitol 84:33-47.
  149. Rougier S, Vouldoukis I, Fournel S, et al. 2008. Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study. Vet Parasitol 153:244-254.
  150. Sakuma M, Setoguchi A, Endo Y. 2009. Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin. J Vet Intern Med 23:493-498.
  151. Sánchez S, Sallovitz J, Savio E, et al. 2000. Comparative availability of two oral dosage forms of albendazole in dogs. Vet J 160:153-156.
  152. Saridomichelakis MN, Mylonakis ME, Leontides LS, et al. 2005. Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in the endemic areas. Vet Parasitol 130:199-205.
  153. 144a. Sasanelli M, Paradies P, Greco B, et al. 2010. Failure of imidocarb dipropionate to eliminate Hepatozoon canis in naturally infected dogs. Vet Parasitol 171:194-199.
  154. Savio E, Domínguez L, Malanga A, et al. 1998. Lipidic matrix of albendazole an alternative for systemic infections. Boll Chem Farmaceut 137:345-349.
  155. Saxon B, Magne ML. 1993. Reversible central nervous system toxicosis associated with metronidazole therapy in three cats. Prog Vet Neurol 4:25-27,
  156. Schettini DA, Costa Val AP, Souza LF, et al. 2003. Distribution of liposome-encapsulated antimony in dogs. Braz J Med Biol Res 36:269-272. Date of electronic publication: Jan 29, 2003.
  157. Schnyder M, Kohler L, Hemphill A, et al. 2009. Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves. Vet Parasitol 160:149-154.
  158. Schwartz RD, Donoghue AR, Baggs RB, et al. 2000. Evaluation of the safety of fenbendazole in cats. Am J Vet Res 61:330-332.
  159. Scorza AV, Lappin MR. 2004. Metronidazole for the treatment of feline giardiasis. J Feline Med Surg 6:157-160.
  160. 150a. Sekis I, Ramstead K, Rishniw M, et al. 2010. Single-dose pharmacokinetics and genotoxicity of metronidazole in cats. J Feline Med Surg 11:60-68.
  161. Slappendel RJ, Teske E. 1997. The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial. Vet Q 19:10-13.
  162. Slater CA, Sickel JZ, Visvesvara GS, et al. 1994. Brief report: successful treatment of disseminated Acanthamoeba infection in an immunocompromised patient. N Engl J Med 331:85-87.
  163. Sobottka I, Albrecht H, Schaefer H, et al. 1995. Disseminated Encephalitozoon (Septata) intestinalis infection in a patient with AIDS: novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole. J Clin Microbiol 33:2948-2952.
  164. Solano-Gallego L, Koutinas A, Miró G, et al. 2009. Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. Vet Parasitol 165:1-18, 2009.
  165. Soto J, Arana BA, Toledo J, et al. 2004. Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis 38:1266-1272.
  166. 155a. Spada E, Proverbio D, Groppetti D, et al. 2011. Meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog. J Am Anim Hosp Assoc 47:67-71.
  167. St. Omer VV. 1978. Efficacy and toxicity of furazolidone in veterinary medicine. Vet Med Small Anim Clin 73:1125-1132.
  168. Stokol T, Randolph JF, Nachbar S, et al. 1997. Development of bone marrow toxicosis after albendazole administration in a dog and a cat. J Am Vet Med Assoc 210:1753-1756.
  169. Strohbusch M, Müller N, Hemphill A, et al. 2009. Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice. Parasitol Res 104:1335-1343.
  170. Sundar S, Jha TK, Thakur CP, et al. 2002. Oral miltefosine for Indian visceral leishmaniasis. N Eng J Med 347:1739-1746.
  171. Sundar S, Rosenkaimer F, Murray HW. 1994. Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-γ. J Infect Dis 170:659-662.
  172. 160a. Tangtrongsup S, Scorza V. 2010. Update on the diagnosis and management of Giardia spp. infections in dogs and cat. Top Comp Anim Med 25:155-162.
  173. 160b. Torreele E, Trunz BB, Tweats D, et al. 2011. Fexinidazole-A new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS Negl Trop Dis 4:e923.
  174. Valladares JE, Alberola J, Estebam M, et al. 1996. Disposition of antimony after the administration of N-methylglucamine antimonate to dogs. Vet Rec 138:181-183.
  175. Valladares JE, Freixas J, Franquelo JA, et al. 1997. Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs. Am J Trop Med Hyg 57:403-406.
  176. Valladares J-E, Riera C, Alberola J, et al. 1998. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Vet Parasitol 75:33-40.
  177. Vercammen F, Fernandez-Perez FJ, del Amo C, et al. 2002. Follow-up of Leishmania infantum naturally infected dogs treated with allopurinol: immunofluorescence antibody test, ELISA and Western blot. Acta Trop 84:175-181.
  178. Vexenat JA, Croft SL, Furtado-Campos JH, et al. 1998. Failure of buparvaquone (Butalex) in the treatment of canine visceral leishmaniasis. Vet Parasitol 77:71-73.
  179. Vial HJ, Gorenflot A. 2006. Chemotherapy against babesiosis. Vet Parasitol 138:147-160.
  180. Viotti R, Vigliano C, Armenti H, et al. 1994. Treatment of chronic Chagas’ disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 127:151-162.
  181. Walker S, Taylor SAN, Lee M, et al. 1998. Amphotericin B in lipid emulsion stability, compatibility, and in vitro fungal activity. Antimicrob Agents Chemother 42:762-766.
  182. Walochnik J, Obwaller A, Gruber F, et al. 2009. Anti-Acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent. J Antimicrob Chemother 64:539-545.
  183. Wasan KM, Wasan EK, Gershkovich P, et al. 2009. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis. J Infect Dis 200: 357-360.
  184. Weiss DJ. 2005. Bone marrow necrosis in dogs: 34 cases (1996-2004). J Am Vet Med Assoc 227:263-267.
  185. Weiss DJ, Klausner JS. 1990. Drug-associated aplastic anemia in dogs: eight cases (1984-1988). J Am Vet Med Assoc 196:472-475.
  186. Woerly V, Maynard L, Sanquer A, et al. 2009. Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis. Parasitol Res 105:463-469.
  187. Wong BK, Woolf TF, Chang T, et al. 1990. Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor in rat and dog. Drug Metab Dispos 18:980-986.
  188. Workman P, White RA, Walton MI, et al. 1984. Preclinical pharmacokinetics of benznidazole. Br J Cancer 50:291-303.
  189. Zajac AM, LaBranche TP, Donoghue AR, Chu TC. 1998. Efficacy of fenbendazole in the treatment of experimental Giardia infection in dogs. Am J Vet Res 59:61-63.
  190. Zygner W, Jaros D, Gójska-Zygner O, et al. 2008. Azithromycin in the treatment of a dog infected with Giardia intestinalis. Pol J Vet Sci 11:231-234.